Apellis Pharmaceuticals I... (APLS)
28.91
1.22 (4.41%)
At close: Jan 15, 2025, 11:46 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -13.44 | -8.41 | -5.35 | -12.47 | -6.15 | -5.63 | -5.9 | -9.36 | -5.46 | -23.53 | -64.08 |
| PS Ratio | 17.91 | 72.75 | 59.96 | 17.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 36.52 | 32.30 | 20.09 | 21.02 | 55.67 | 4.46 | 2.02 | 10.67 | 7.26 | 19.19 | 56.13 |
| P/FCF Ratio | -11.93 | -10.65 | -7.07 | -25.91 | -8.95 | -5.47 | -6.46 | -9.76 | -13.46 | -25.47 | -73.69 |
| P/OCF Ratio | -11.94 | -10.68 | -7.09 | -26.79 | -9.02 | -5.47 | -6.46 | -9.76 | -13.46 | -25.52 | -73.69 |
| OCF/S Ratio | -1.5 | -6.81 | -8.46 | -0.64 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.57 | 0.66 | 1.06 | 1.85 | 4.59 | 0.17 | 0.18 | n/a | n/a | n/a | n/a |
| Quick Ratio | 2.50 | 3.78 | 6.13 | 7.15 | 5.67 | 11.89 | 27.77 | 7.52 | 11.89 | 13.05 | 7.16 |
| Current Ratio | 3.10 | 4.29 | 6.25 | 7.15 | 5.67 | 11.89 | 27.77 | 7.52 | 11.89 | 13.17 | 7.67 |
| Asset Turnover | 0.50 | 0.10 | 0.08 | 0.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -17.48 | -18.23 | -40.5 | -7.14 | -54.5 | -50.91 | -523.83 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -2.72 | -3.84 | -3.76 | -1.69 | -9.05 | -0.79 | -0.34 | -1.14 | -1.33 | -0.82 | -0.88 |
| Return on Assets (ROA) | -0.67 | -0.86 | -0.85 | -0.36 | -0.8 | -0.63 | -0.28 | -0.99 | -1.22 | -0.75 | -0.76 |
| Return on Capital (ROIC) | -0.96 | -1 | -0.72 | -0.26 | -0.89 | -0.69 | -0.29 | -1.15 | -1.33 | -0.85 | -0.89 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 85.25% | 92.53% | 92.19% | 90.01% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -133.29% | -864.7% | -1.12K% | -137.59% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -132.76% | -863.81% | -1.12K% | -136.86% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -130.39% | -788.38% | -805.67% | -85.27% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -150.16% | -683.18% | -847.66% | -66.19% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -124.87% | -818.58% | -1.10K% | -124.57% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |